BIOMARIN PHARMACEUTICAL INC - NOTE 1.500%10/1

Historical Institutional Holders from Q1 2014 to Q4 2020

All holders as of December 31, 2020
Q4 2020
Type / Class
Debt / NOTE 1.500%10/1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2020 Q4 $0 $0 -$356M 0
2020 Q3 $358M $356M +$39.5M $1.00 30
2020 Q2 $301M $403M +$10.7M $1.32 35
2020 Q1 $309M $327M -$69.7M $1.06 42
2019 Q4 $376M $409M +$23.3M $1.08 41
2019 Q3 $355M $367M +$12.7M $1.03 41
2019 Q2 $338M $380M +$29.5M $1.12 39
2019 Q1 $312M $355M -$5.42M $1.14 36
2018 Q4 $314M $350M +$2.82M $1.11 36
2018 Q3 $310M $372M +$15.7M $1.20 39
2018 Q2 $297M $350M -$5.72M $1.18 39
2018 Q1 $302M $334M -$10.5M $1.10 38
2017 Q4 $308M $365M +$35.5M $1.19 38
2017 Q3 $278M $334M -$62.7M $1.20 38
2017 Q2 $333M $397M -$8M $1.19 38
2017 Q1 $340M $403M +$1.09M $1.18 40
2016 Q4 $339M $400M +$28.9M $1.18 39
2016 Q3 $313M $392M +$17.7M $1.25 42
2016 Q2 $301M $352M +$12.1M $1.16 44
2016 Q1 $292M $348M +$20.5M $1.19 43
2015 Q4 $271M $383M -$18.3M $1.34 42
2015 Q3 $286M $408M -$14.7M $1.34 40
2015 Q2 $282M $472M -$906M $1.59 41
2015 Q1 $300M $457M -$70.4M $1.51 42
2014 Q4 $354M $434M -$728M $1.23 38
2014 Q3 $375M $412M +$19.7M $1.10 40
2014 Q2 $352M $372M +$32.1M $1.05 35
2014 Q1 $325M $362M +$20.3M $1.11 37